Cargando…
The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
SIMPLE SUMMARY: Breast cancer represents the most frequently diagnosed carcinoma and the leading cause of cancer death in women. Despite advances achieved in systemic therapy, about one-third of all patients relapse and develop a metastatic disease, which ultimately leads to breast cancer deaths. In...
Autores principales: | Augimeri, Giuseppina, Giordano, Cinzia, Gelsomino, Luca, Plastina, Pierluigi, Barone, Ines, Catalano, Stefania, Andò, Sebastiano, Bonofiglio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564201/ https://www.ncbi.nlm.nih.gov/pubmed/32937951 http://dx.doi.org/10.3390/cancers12092623 |
Ejemplares similares
-
Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer
por: Augimeri, Giuseppina, et al.
Publicado: (2020) -
Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
por: Gionfriddo, Giulia, et al.
Publicado: (2020) -
N-Eicosapentaenoyl Dopamine, A Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages
por: Augimeri, Giuseppina, et al.
Publicado: (2019) -
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
por: Rovito, Daniela, et al.
Publicado: (2016) -
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication
por: Giordano, Cinzia, et al.
Publicado: (2019)